Search research articles
Contact Us
Filters
Showing results (41-50 of 64) with videos related to
Page
of 7
Sort By:
Journal of Immunological Methods
|
April 2, 1993
In vivo and in vitro primed lymphocytes. Correlation of cytochemically detected BLT-specific lymphoid serine protease with cytotoxic activity
L Wagner, G Sunder-Plassmann, W Base, et al.
Leukemia Research
|
January 1, 1991
Continuous intravenous infusion of high dose recombinant interleukin 2 for advanced lymphomas--a phase II study
S H Lim, C P Worman, T Callaghan, et al.
Klinische Wochenschrift
|
July 15, 1987
Natural IFN-alpha therapy in hairy-cell leukaemia (namalva-type IFN--Wellferon)
C P Worman, A B Nethersell, J M Bottomley, et al.
Leukemia
|
April 1, 1987
The U.K. experience with human lymphoblastoid interferon in HCL: a report of the first 50 cases
C P Worman, D Catovsky, J C Cawley, et al.
Acta Haematologica
|
January 1, 1988
Atypical mycobacterial infection in alpha interferon-treated hairy cell leukaemia
F J Giles, S J Russell, C P Worman, et al.
British Journal of Haematology
|
March 1, 1980
Phenotypic characterization of a virus producing line established from a patient with leukaemia/lymphoma: comparison with T-lymphoblastic and myeloblastic lines
A Karpas, C P Worman, G Khalid, et al.
British Journal of Haematology
|
October 1, 1994
Interferon-alpha up-regulates bcl-2 expression and protects B-CLL cells from apoptosis in vitro and in vivo
A P Jewell, C P Worman, P M Lydyard, et al.
British Journal of Haematology
|
February 1, 1994
Serum macrophage colony-stimulating factor (M-CSF) levels correlate with clinical response to interferon-alpha in patients with early-stage B-CLL
A P Jewell, K L Yong, C P Worman, et al.
Scandinavian Journal of Haematology
|
March 1, 1982
A megakaryocytic thrombocytopenia associated with the excess of Leu 2a+ suppressor cells
C P Worman, K H Mills, D C Linch, et al.
Nature
|
July 21, 1977
A human leukaemic cell expressing hybrid membrane phenotypes
G F Burns, A A Nash, C P Worman, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 64) with videos related to
Sort By:
Page
of 7
Journal of Immunological Methods
|
April 2, 1993
In vivo and in vitro primed lymphocytes. Correlation of cytochemically detected BLT-specific lymphoid serine protease with cytotoxic activity
L Wagner, G Sunder-Plassmann, W Base, et al.
Leukemia Research
|
January 1, 1991
Continuous intravenous infusion of high dose recombinant interleukin 2 for advanced lymphomas--a phase II study
S H Lim, C P Worman, T Callaghan, et al.
Klinische Wochenschrift
|
July 15, 1987
Natural IFN-alpha therapy in hairy-cell leukaemia (namalva-type IFN--Wellferon)
C P Worman, A B Nethersell, J M Bottomley, et al.
Leukemia
|
April 1, 1987
The U.K. experience with human lymphoblastoid interferon in HCL: a report of the first 50 cases
C P Worman, D Catovsky, J C Cawley, et al.
Acta Haematologica
|
January 1, 1988
Atypical mycobacterial infection in alpha interferon-treated hairy cell leukaemia
F J Giles, S J Russell, C P Worman, et al.
British Journal of Haematology
|
March 1, 1980
Phenotypic characterization of a virus producing line established from a patient with leukaemia/lymphoma: comparison with T-lymphoblastic and myeloblastic lines
A Karpas, C P Worman, G Khalid, et al.
British Journal of Haematology
|
October 1, 1994
Interferon-alpha up-regulates bcl-2 expression and protects B-CLL cells from apoptosis in vitro and in vivo
A P Jewell, C P Worman, P M Lydyard, et al.
British Journal of Haematology
|
February 1, 1994
Serum macrophage colony-stimulating factor (M-CSF) levels correlate with clinical response to interferon-alpha in patients with early-stage B-CLL
A P Jewell, K L Yong, C P Worman, et al.
Scandinavian Journal of Haematology
|
March 1, 1982
A megakaryocytic thrombocytopenia associated with the excess of Leu 2a+ suppressor cells
C P Worman, K H Mills, D C Linch, et al.
Nature
|
July 21, 1977
A human leukaemic cell expressing hybrid membrane phenotypes
G F Burns, A A Nash, C P Worman, et al.
Page
of 7